MedTrace Logo

Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin Evaluation of Symptomatic Heart Failure Study

NCT01291836 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 930

Last updated 2024-01-03

Study results available
· View outcomes & findings →

Summary

AKINESIS is a clinical study to assess the utility of blood and urine NGAL tests in predicting worsening kidney function in patients who present with acute heart failure (AHF) and who are treated with diuretics. It is believed that rising NGAL levels in the blood and/or urine can predict acute kidney injury. It is also believed that patients who are admitted to the hospital with high NGAL levels in the blood/urine will have poorer outcomes.

Conditions

Sponsors & Collaborators

  • Abbott Diagnostics Division

    collaborator INDUSTRY

  • Alere, Inc.

    collaborator INDUSTRY

  • Alere San Diego

    lead INDUSTRY

Principal Investigators

  • Alan Maisel, MD · University of California, San Diego Medical Center/Veterans Affairs Medical Center, San Diego

  • Patrick Murray, MD · University College of Dublin School of Medicine and Medical Science/Mater Misericordiae University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2013-10-31
Completion
2015-06-30

Countries

  • United States
  • Greece
  • Ireland
  • Italy
  • Netherlands
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01291836 on ClinicalTrials.gov